ACI is excited to announce our 7th Lung Cancer Screening & Continuum of Care Conference on December 12-13, 2018. A dedicated forum to learn and network with representatives from organizations nationwide that are prepared to deliver superior service in thoracic oncology.
Our event will be an exploration of techniques and policy changes to better fit lung screening programs through case studies, research findings and organizational models from renowned healthcare and radiology institutions. The top thoracic oncology programs in the country will showcase their successes and share strategies in achieving excellence in patient care and cost-effective management.
This two-day event will focus on implementing lung screening programs and services to maximize competitive advantage, meet increased demand and exceed patient satisfaction. The goal of this event is to bring industry leaders together, highlight the best practice achievements, and discuss the current issues and developments in imaging services for the thoracic oncology community.
Lung cancer is the leading cause of cancer-related deaths in the United States. This largely stems from lung cancer’s minimal symptoms in its early stages, which is when the disease is most treatable. For this reason, there is a push for regions to offer screening services for their populations, enabling potential patients to receive care at the most opportune time. Providing this service to potential patients comes with its own challenges, such as motivating patients to get screened regularly, generating funding for these services, raising awareness in your community and many more.
Through a series of presentations, sessions, and panel discussions, this event will cover some of the major current concerns of the industry.
Moffitt Cancer Center is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 49 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s scientific excellence, multidisciplinary research, and robust training and education. Moffitt is a Top 10 cancer hospital and has been nationally ranked by U.S. News & World Report since 1999. Moffitt devotes more than 2 million square feet to research and patient care. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 6,000 team members, Moffitt has an economic impact in the state of $2.1 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), or visit MOFFITT.org.
Chief Medical Officer
Moffitt Cancer Center
Charles Mulligan Jr.
Chief of Thoracic Surgery
Christiana Care Health System
Tobacco Treatment Specialist
Gulfcoast South AHEC
Oncology Nurse Navigator
Lee Regional Cancer Center
APRN FNP-C OCN, Nurse Practitioner
Martin Health System – Center for Lung Health
Lung Cancer Screening Program Director
Senior Healthcare Data Analyst
Section Chief of Pulmonary & Critical Care Medicine
Moffitt Cancer Center
Associate Member for the Department of Cancer Epidemiology
Moffitt Cancer Center
Chief of Interventional Pulmonary Medicine
NYU Langone Health
Amie J. Miller
ARNP AOCNP CTTS, Lung Cancer Screening Program Coordinator
Sarasota Memorial Health Care System
Chief Medical Officer
Nurse Practitioner Director – Lung Cancer Screening Program
Cancer Epidemiologist and Director, Office of Community Engaged Research and Implementation Science (OCERIS)
University of Illinois Cancer Center
Robert A. Winn
MD, Associate Vice Chancellor for Community-Based Practice
University of Illinois Cancer Center
This two-day conference will offer excellent opportunities for you to network with your peers: CEOs, CIOs, CSOs, Vice-Presidents, Directors, and Senior Managers responsible for
Key titles include:
At Siemens Healthineers, our purpose is to enable healthcare providers to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, and improving patient experience, all enabled by digitalizing healthcare. An estimated 5 million patients globally everyday benefit from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine, as well as digital health and enterprise services. We are a leading medical technology company with over 170 years of experience and 18,000 patents globally. With more than 48,000 dedicated colleagues in 75 countries, we will continue to innovate and shape the future of healthcare.
Clocate.com is a leading international directory for worldwide conferences and exhibitions. Clocate.com is equipped with a unique and comprehensive search that helps you find easily any event in any category or location. Each event includes detailed information, like, description, dates, location, map, prices, link to the official event’s website and more… If you search for a conference or exhibition in areas such as Industry and manufacturing, Health and medicine, Technology and IT, Business and finance, sciences, education, services (banking, insurance, tourism, Hospitality and more), government, environment, life style and arts, you’ll find it in Clocate.com.
Drug Discovery Today covers the whole of the preclinical drug discovery process. The reviews are cutting edge, written by experts in their respective fields and cover all aspects of drug discovery from genomic and proteomic approaches, computational drug design, medicinal chemistry and the translation of these sciences to therapies.
Journal for Clinical Studies is a globally distributed publication with an established presence across the world. A peer reviewed journal, it looks into global studies within clinical research, covering multisite studies and evaluations of emerging markets. With an audience of over 80,000 clinical studies professionals worldwide, the JCS readership includes leading pharmaceutical companies, bio tech companies, CRO’s and government and non-government agencies. Each bimonthly issue has a print copy distribution figure of 24,000 copies, providing strong access to the international market. JCS is published both in print and online.
Pharma Journalist is a paramount B2b online magazine platform exhibiting targeted and succinct information concerning the world of Pharmaceutical Industry therefore keeping a tab on the updated and latest updates and trends concerning the field. Our widespread and market specific content write-ups cater to Industry professionals intending to keep pace with this dynamic and revolutionary industry. Articles like latest news, trends, analysis, market reports, press releases, whitepapers , case studies, etc, enable further insight as well as an in-depth interpretation of industry trends. Our editorial staff is committed to disseminating concise facts and information to its readers and subscribers by collating credible information from known sources and decoding them in the form of innumerable content pieces. Ranging from objective facts to subjective, analytical studies enables a holistic view of the topics scouted for. It is noteworthy that Pharma Journalist which is a product of Kellen Media also offers a plethora of online marketing services aiding companies and organizations to reach out to targeted audience based on the geographical and demographic profiles ensuring enhanced reach and visibility garnered for their products or events paving way for accentuated brand awareness.
Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.
PharmaVOICE magazine reaches more than 46,000 BPA qualified subscribers and 60,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.
THE PHARMA WORLD is the first and the only bi-monthly Pharmaceutical and Health Journal of its kind in Bangladesh catering to the needs of Pharmaceutical Industries, Physicians, Healthcare Providers and all other stakeholders related to this sector for the last 12 years. The Journal is also designed to disseminate information about the advancement of research & development in pharmaceutical sector and medical science, thereby, constantly updating readers on this multi-dimensional segment. THE PHARMA WORLD also has a Consultancy Division which is engaged in a wide range of activities which include Export Promotion, Bioequivalence Study, Market Survey, Training, and organizing Seminar/Workshop/Conference on matters relating to the pharma sector.
VenueDir is a leading directory for major venues around the world with a search by location, size of venue or type of event (conference, seminar, exhibition, wedding and others). In VenueDir you can find the services provided by the venue, including, food and beverages, accomodation, onsite parking, on-site support, audio and video and more. Venuedir provides an option to submit a request for proposal (RFP) to all suitable venues.
10times is the world’s largest service provider for business events. We are using technology to change the way our millions of users discover and experience events. Spread across 10,000 cities, we are in the process of developing a cutting edge mobile technology in order to re-invent how this industry conducts business.
ASDReports – Market Research Reports & Industry Analysis Are you mastering your market? Do you know what the market potential is for your product, who the market players are and what the growth forecast is? We offer global, regional or country specific research studies for almost any market imaginable. Our market research reports consist of market analysis with statistical and analytical information, applications, industry analysis, market shares, technology and technology shifts, important players, and the developments in the market. At ASDReports.com, you will find all the globally available market research and company reports from well-respected market research companies, all leaders in their field. ASDReports is totally independent and serves its customers by providing the most reliable market research available, as we understand how important this is for you.
Established in 2009 in Singapore, Eco-Business is an independent media company serving Asia Pacific’s responsible business and sustainable development community. Our team is helmed by managing editor Jessica Cheam, an award-winning journalist and established expert and speaker on sustainability in Asia Pacific; research director Tim Hill who has 20 years’ experience in leading business and market research for government agencies and MNCs; executive editor Teymoor Nabili, a veteran current affairs TV presenter in Asia; and deputy editor Robin Hicks, a veteran journalist with experience across the region. We expanded to Sydney in late 2015 and now operate from both Singapore and Australia.